Hepion Historical Cash Flow
| HEPA Stock | USD 0.67 0.05 8.06% |
Analysis of Hepion Pharmaceuticals cash flow over time is an excellent tool to project Hepion Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 13.6 K or Total Cash From Financing Activities of 4.3 M as it is a great indicator of Hepion Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hepion Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hepion Pharmaceuticals is a good buy for the upcoming year.
Hepion |
About Hepion Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hepion balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hepion's non-liquid assets can be easily converted into cash.
Hepion Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Hepion Pharmaceuticals value has been used up. For tax purposes Hepion Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Hepion Pharmaceuticals must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Hepion Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hepion Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.At present, Hepion Pharmaceuticals' Other Non Cash Items is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 22.4 M, whereas Change In Cash is projected to grow to (34.6 M).
Hepion Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Hepion Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hepion Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 11.1M | 26.8M | 50.6M | (40.2M) | (36.4M) | (34.6M) | |
| Free Cash Flow | (7.6M) | (16.3M) | (31.4M) | (35.0M) | (40.9M) | (38.9M) | |
| Other Cashflows From Financing Activities | 13.4M | 198.6K | (165.6K) | (2.0M) | 1K | 950.0 | |
| Other Non Cash Items | 157.3K | 140K | 2.3M | 1.5M | 4.1M | 4.3M | |
| Total Cash From Operating Activities | (7.6M) | (16.2M) | (31.2M) | (35.0M) | (40.9M) | (38.8M) | |
| Net Income | (6.7M) | (20.4M) | (32.7M) | (42.2M) | (48.9M) | (46.5M) | |
| Total Cash From Financing Activities | 18.7M | 43.1M | 82.0M | (5.1M) | 4.5M | 4.3M | |
| End Period Cash Flow | 13.9M | 40.7M | 91.3M | 51.2M | 14.8M | 22.4M | |
| Change In Working Capital | (754.6K) | 1.6M | (5.6M) | 3.2M | 3.0M | 3.1M | |
| Begin Period Cash Flow | 2.8M | 13.9M | 40.7M | 91.3M | 51.2M | 53.7M | |
| Depreciation | 26.7K | 34.5K | 86.1K | 77.5K | 67.1K | 37.9K | |
| Sale Purchase Of Stock | 4.7M | 147K | 42.9M | 176.6K | (21M) | 0.0 | |
| Stock Based Compensation | 66.2K | 2.4M | 4.7M | 2.6M | 1.3M | 1.8M | |
| Total Cashflows From Investing Activities | (51.5K) | (85.8K) | (130.4K) | (14.1K) | (16.2K) | (17.0K) | |
| Investments | (51.5K) | (85.8K) | (130.4K) | (14.1K) | (30.3K) | (31.8K) | |
| Dividends Paid | 147K | 10K | 11K | 5K | 1K | 950.0 | |
| Change To Operating Activities | (330.2K) | (1.4M) | (4.5M) | 907.0K | 816.3K | 857.1K | |
| Change To Netincome | (605.1K) | 2.5M | 7.0M | 4.0M | 4.6M | 4.8M | |
| Change To Liabilities | (424.4K) | 3.0M | (1.1M) | 2.2M | 2.6M | 2.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.41) | Return On Assets (0.93) | Return On Equity (1.90) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.